Peripheral neuropathy is a condition where damage resulting from mechanical or pathological mechanisms is inflicted on nerves within the peripheral nervous system (PNS). Physical injury is the most common cause and may result in nerves being partially or completely severed, crushed, compressed or stretched. Other causes include metabolic or endocrine disorders, with *e.g*., 50-60% of people with diabetes eventually suffering from various peripheral neuropathies. In contrast to the central nervous system (CNS), the PNS possesses a unique ability to regenerate. However, despite the considerable capacity for regrowth upon injury, PNS regeneration is far from complete and functional recovery rarely returns to pre-injury levels. Furthermore, induced neuropathic pain is often permanent and complex to control, and the common consequence of nerve injury is thus a significant impact on quality of life and daily activities.

Scientific research in the molecular and cellular effects following PNS injury has largely focused on neurons and Schwann cells, whereas considerably less attention has been given to the satellite glial cells (SGCs) -- a cell type in intimate contact with the sensory neurons and with a neuron supporting function. Growing evidence over the past decade is, however, establishing SGCs as important components of PNS functionality and in post-injury responses such as chronic pain states. Several SGCs, interconnected by gap junctions, together form a sheath around one neuronal soma ([**Figure 1**](#F1){ref-type="fig"}), leaving a gap of just 20 nm between the SCGs and the neuron -- the width of a synapse. A layer of connective tissue encloses this functional unit of neuron soma and SGCs. The non-neuronal face of the slimly flattened SGCs has a basement membrane, which together with the endothelial basement membrane constitutes a blood-neuron barrier (Pannese, 2010). Through expression of a number of receptors and channels, SGCs are believed to stabilize the neuronal microenvironment, supporting normal neuron function and providing electrical insulation. This intimate and isolated structural arrangement between SGCs and soma strongly implies that soma-SGC communication is a major determinant of neuronal activity, and that understanding injury-induced changes in this communication is important for understanding the neuronal changes and activity following peripheral nerve injury.
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Profound changes can be observed in the soma of dorsal root ganglion (DRG) neurons upon peripheral nerve injury, ranging from altered protein expression, structural changes and even cell death depending on the degree of injury and the neuronal subtype. A series of morphologic changes can be observed as early as a few hours after injury, entailing cell body and nucleolar swelling as well as nuclear eccentricity. The purpose of these changes is to initiate an appropriate response to traumatic stress, switching the neurons from the steady-state production of neurotransmitters and housekeeping proteins to a "regrowth mode". This involves production of components for cytoskeletal and axonal reconstruction and growth-related proteins including nitric oxide, adenosine triphosphate, neuropeptides, neurotrophic factors and their receptors. Several biological factors influence the communication between peripheral nerves and tissues following injury, including a variety of cytokines and growth factors. Similar conditions can be observed during the development of the nervous system where the PNS strongly depends on trophic stimulation for survival, differentiation, sprouting and maturation (Geuna et al., 2009). As damage to the adult PNS induces cellular mechanisms that control neuronal differentiation as well as growth and connectivity during development, "studies of neurotrophic factors represent one of the most promising areas of research aimed at finding new, more effective treatments for peripheral neuropathies" according to National Institute of Neurological Disorders and Stroke.

The family of neurotrophins consists of nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and neurotrophin-4 (NT-4), which can bind to two structurally unrelated receptors: the neurotrophin receptor p75^NTR^ and the tropomyosin receptor kinases (TrkA, -B, and -C). Binding of neurotrophins to the Trk receptors is selective with NGF binding to TrkA, BDNF and NT-4 to TrkB and NT-3 to TrkC. However, many neurons co-express Trk receptors and p75^NTR^, which together strengthen the affinity and specificity of the neurotrophins for the Trk receptors. The neurotrophins bind to their respective Trk receptors to mediate survival and differentiation but can also provide survival signaling or affect cytoskeletal organization and neurite outgrowth *via* p75^NTR^. Yet, p75^NTR^ is better recognized for its ability to induce cell death signaling *via* binding of various intracellular adaptor proteins (Chao, 2003). Uninjured SGCs have been reported to express neurotrophins and their receptors. Thus, TrkA and p75^NTR^ are found in the SGC cytoplasm and in the SGC-neuron border, and expression of TrkB, more specifically truncated TrkB without the cytosolic kinase domain, has also been described. Furthermore, TrkC mRNA and immunoreactivity in some SGCs surrounding large neurons has also been reported. Finally, NT-3, NGF and BDNF have been observed in SGCs both at mRNA and protein levels.

In general, the SGCs respond rapidly when injury is inflicted on the neuron, which they encapsulate. Dynamic neuron-SGC communication by P2X receptors, NMDA receptors and glutamate transporters in SGCs increases SGC-SGC communication *via* gap junctions and initiates a general increase in proliferation and cytokine communication. This SGC response suggests that SGC involvement in post-injury events, such as regeneration and the initiation and/or maintenance of neuropathic pain, is a highly rational assumption. In accordance with this, knockdown of the gap junction protein connexin 43 as well as the use of pharmacological gap junction blockers has been demonstrated to decrease pain behavior in rodents (Hanani, 2005). Several observations also demonstrate that SGCs, but not neurons, increase NGF and NT-3 mRNA following injury. Intriguingly, administration of gap junction inhibitors during injury is found to significantly decrease the number of NGF-positive SGCs. Although the direct effects of SGC-derived NGF on DRG neurons are still to be demonstrated, other observations indicate involvement of SGCs in neurotrophin signaling. Thus, NGF dependent sprouting of sympathetic axons into sensory ganglia following nerve injury is believed to underlie the phenomenon of sympathetically maintained pain, where increased pain is triggered when sympathetic activity is induced.

Following nerve injury, sprouts of sympathetic terminals originating from the vasculature form synaptic terminals or "baskets" around selected large DRG sensory neurons. Sympathetic nerves express and respond to neurotrophins, and the observed sympathetic sprouting clearly depends on NGF as antibodies against NGF or NT-3, delivered by an osmotic mini-pump to the DRG *via* the transected nerve, was found to reduce sprouting significantly. It has been reported that uninjured and even contralateral DRGs to some extent can be affected by sympathetic sprouting, although this might reflect that any surgical procedure *per se* may initiates local tissue inflammation and, thus, induce systemic responsiveness to released NGF. In general, the sympathetic sprouting around the axotomized neurons is associated with p75^NTR^-positive SGCs. Based on the L~5~ spinal nerve ligation (L~5~--SNL) model, nerve injury results in reduced p75^NTR^ expression in injured (L~5~) neurons, whereas the expression increases in uninjured but affected L~4~ neurons. However, whereas injured neurons decrease p75^NTR^ expression, the surrounding SGCs experience a dramatic upregulation of p75^NTR^ levels in response to injury. Increased expression of p75^NTR^ is primarily found in SGCs surrounding large neurons, and co-localization studies further demonstrate that sympathetic sprouting mainly associates with the p75^NTR^-positive SGCs surrounding these large neurons. Furthermore, other findings show that sympathetic fibers wrap up around the SGCs rather than around the neurons, and that p75^NTR^ knockout mice display impaired sympathetic sprouting into the DRGs. Thus, increased expression of NGF and p75^NTR^ by SGCs potentially provides an explanation for the abnormal growth of sympathetic fibers in DRGs after peripheral nerve injury. However, whether increased NGF expression by SGCs is restricted to the p75^NTR^-positive SGCs surrounding large injured neurons and how SGC p75^NTR^ is involved in the supposed SGC-derived NGF attraction of sympathetic sprouts is still to be explained. Only half of the p75^NTR^-positive neuron-SGC units attract sympathetic sprouts, and p75^NTR^-positive SGCs surrounding small diameter neurons do not attract sympathetic sprouts, suggesting that sympathetic sprouting mechanisms include, but extend beyond, SGC-related increases in NGF and p75^NTR^ expression (Richner et al., 2014).

Interestingly, a recent study suggests that the neuronal expression level of p75^NTR^ is critical for SGC responsiveness. Thus, reduction of neuron p75^NTR^ levels by oligonucleotides to simulate neuronal injury induced a reactive state in the corresponding SGCs, as measured by increased expression of p75^NTR^, GFAP and connexin 43 (Nadeau et al., 2014). This finding clearly suggests that the neurotrophin system is active in the adult organism, and that neurotrophin mediated signaling between neurons and SGC could be involved in injury states.

A major challenge in the exploration of SGC function lies in their intimacy with the sensory neurons, forming a functional unit. Recent experiments have shown that isolation of SGCs in culture results in morphological changes and a loss of selected marker proteins such as glutamine synthetase whereas another used SGC marker, P2X~7~, is largely unchanged (Belzer et al., 2010). This result indicates the limited use of isolated primary SGC cultures as a meaningful experimental system to explore the expression and regulation of SGC specific proteins. Consequently, *in vivo* analysis in which the injured neurons trigger SGC activation and the subsequent bidirectional communication is, however challenging it may be, the appropriate system. To progress along this avenue, selective knock-down of signaling molecules or their receptors in either the neurons or the SGCs in the adult mice could be very informative. The development of the tamoxifen-inducible Advillin-Cre mouse allows specific and acute knock-out of proteins of interest in adult DRG sensory neurons. Future development of a corresponding SGC-specific and inducible Cre would, paralleled by the Advillin-Cre model, allow very detailed analysis of the functions of a large variety of proteins *in vivo* and unravel details on the impact of SGC signals on the neuronal soma and vise versa. Subjecting such mice to various injury and inflammatory paradigms of the PNS could be the next path to further study the impact of neurotrophin signaling in the SGC-neuron system on chronic pain states and regenerative issues.

To conclude, neurotrophin signaling is essential for key phases of PNS development, including cellular survival, differentiation and neuronal sprouting. Following injury to peripheral nerves, neurotrophin signaling pathways are reactivated in neurons and SGCs, presumably partaking in the signaling processes facilitating nerve regeneration and functional recovery. Unfortunately, nerve recovery is often far from complete, and unwanted side effects of neurotrophin signaling in *e.g*., the spinal cord further initiate processes that lead to chronic neuropathic pain symptoms. Thus, there is an immense need to increase our understanding of fundamental biological aspects of neurotrophins and their receptors in neuronal and glial biology as well as their inter-cellular communication. Hopefully, future research will facilitate the development of better treatments to increase functional nerve recovery after injury and to prevent or alleviate neuropathic pain.
